| Product Name | Landiolol - API |
| Product Code | DA-L113-a |
| Chemical name | Landiolol |
| Synonyms | ((S)-2,2-Dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-((S)-2-hydroxy-3-((2-(morpholine-4-carboxamido)ethyl)amino)propoxy)phenyl)propanoate; 4-[(2S)-2-Hydroxy-3-[[2-[(4-morpholinylcarbonyl)amino]ethyl]amino]propoxy]benzenepropanoic Acid [(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl Ester; [(4S)-2,2-Dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate; |
| Impurity | NA |
| CAS Number | 133242-30-5 |
| Alternate CAS # | NA |
| Molecular form | C25H39N3O8 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 509.6 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | enzyme activators,enzyme inhibitors,pharmaceutical standards,impurities,metabolites,fine chemicals |
| Boiling Point | NA |
| Applications | Landiolol is an ultra-short acting beta blocker that is used to treat patients with cardiac arrhythmias and is also used to treat tachycardia during anasthesia. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
